NDA Partners
Global strategy consulting firm NDA Partners has added three senior industry executives to its roster of Premier Expert consultants:
- Former Director of the Division of Monoclonal Antibodies (DMA) at the US Food & Drug Administration (FDA) Dr. Kathryn Stein (left)
- Dr. howard Lee (middle), a Professor and head of the Clinical Trials Center, Seoul National University Hospital, Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine
- Dr. In-Jin (Theo) Jang (right), a professor in the Department of Clinical Pharmacology at the Seoul National University College of Medicine and Director of the Department of Pharmacology at the Seoul National University Hospital
“Our new Premier Experts strengthen our position as one of the premier strategy consulting firms in the world in the area of medical product development,” said NDA Chairman Dr. Carl Peck. “We are pleased with the extraordinary depth of expertise and accomplishment that they will bring to bear on the solutions we provide for our clients.”